Amplifiz Podcast

Text Amplifiz Podcast

It has been a long time since we were hoping to have Veeva Systems on the show — and we finally made it happen!
Veeva is the leading industry cloud for life sciences, and we had a LOT of questions to ask!

On this episode of the Amplifiz Pharma and MedTech Innovations Podcast, our host and founder Guillaume Villard sits down with Tristan Theurier, General Manager APAC at Veeva Systems, for a rich, candid and grounded conversation about why — and how — the Pharma Commercial Playbook must evolve to improve its relevance and performance in the AI era.

𝗪𝗛𝗢 𝗦𝗛𝗢𝗨𝗟𝗗 𝗟𝗜𝗦𝗧𝗘𝗡 𝗧𝗢 𝗧𝗛𝗜𝗦 𝗘𝗣𝗜𝗦𝗢𝗗𝗘?
This episode is highly relevant for Pharma, MedTech and Life Sciences professionals and leaders across Commercial, Sales, Marketing, Medical Affairs, Commercial Excellence, Data & AI, Digital, Technology / IT, Market Access, Customer Experience, C-suite and Executive Leadership.

Especially for professionals asking:
• How is AI changing Healthcare — and what does this truly mean for Pharma Commercial organizations?
• How can Pharma companies adapt their Commercial Playbook to remain relevant in the AI era?
• How can we move beyond AI hype and avoid getting stuck in endless AI pilots?
• How will AI change the role of Sales Representatives, MSLs, Marketing and Medical Affairs?
• How can Pharma create content that is relevant to both humans and AI?
• How can AI help us better understand HCP needs and barriers to treatment adoption?
• What does “Return on AI” really mean?
• How can AI help deliver measurable outcomes?

𝗧𝗵𝗶𝘀 𝗲𝗽𝗶𝘀𝗼𝗱𝗲 𝗶𝘀 𝗽𝗮𝗰𝗸𝗲𝗱 𝘄𝗶𝘁𝗵 𝗶𝗻𝘀𝗶𝗴𝗵𝘁𝘀, 𝗱𝗮𝘁𝗮, 𝗿𝗲𝗮𝗹-𝗹𝗶𝗳𝗲 𝗲𝘅𝗮𝗺𝗽𝗹𝗲𝘀 𝗮𝗻𝗱 𝘀𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗰 𝗽𝗲𝗿𝘀𝗽𝗲𝗰𝘁𝗶𝘃𝗲𝘀.

The conversation begins by exploring how AI is changing the behaviour of Patients and Healthcare Professionals.

Patients now have access to more information than ever before and are increasingly using AI to understand their health, conditions and treatments.

For Healthcare Professionals, the challenge is different. Medical knowledge is expanding at an extraordinary pace. The problem is no longer simply accessing information — it is finding the right information, understanding what is relevant and efficiently triaging increasingly complex questions.

𝗧𝗛𝗘 𝗧𝗥𝗔𝗗𝗜𝗧𝗜𝗢𝗡𝗔𝗟 𝗣𝗛𝗔𝗥𝗠𝗔 𝗖𝗢𝗠𝗠𝗘𝗥𝗖𝗜𝗔𝗟 𝗣𝗟𝗔𝗬𝗕𝗢𝗢𝗞 𝗜𝗦 𝗖𝗛𝗔𝗡𝗚𝗜𝗡𝗚
Access to Healthcare Professionals has been declining for years, and AI and the increasing availability of on-demand information may accelerate this trend.

The traditional model of a sales representative providing information to an HCP during a scheduled meeting is no longer sufficient when that same HCP can access relevant information instantly, at any time, through AI-powered solutions.

So what does the future Pharma Commercial model look like?
Tristan describes a future built around four interconnected components:
• Field teams
• Digital engagement
• Content
• AI Agents

The role of the field force is likely to evolve, with more specialized roles and a greater focus on expertise.
Digital engagement can become the starting point for more relevant and demand-triggered interactions with Healthcare Professionals.
Content needs to become more targeted, more personalized and increasingly designed to be understood by both humans and AI.
AI Agents will also increasingly become part of how Pharma organizations operate.
AI can help capture, structure and interpret the meaning behind interactions with HCPs. This could fundamentally change how Pharma companies understand HCP needs — and how Commercial, Marketing, Medical and Field teams work together to address them.

𝗧𝗛𝗘 𝗙𝗨𝗧𝗨𝗥𝗘 𝗢𝗙 𝗔𝗜 𝗜𝗡 𝗣𝗛𝗔𝗥𝗠𝗔: 𝗢𝗨𝗧𝗖𝗢𝗠𝗘𝗦 𝗙𝗜𝗥𝗦𝗧
The conversation also explores one of the most important questions facing every Pharma and Life Sciences organization today:
How do we move from AI experimentation to AI at scale?
The answer may lie in shifting the focus from AI consumption to outcomes.
🎙️ WATCH NOW FOR ALL THE INSIGHTS!

🔗 𝗖𝗼𝗻𝗻𝗲𝗰𝘁 𝘄𝗶𝘁𝗵 𝘁𝗵𝗲 𝗦𝗽𝗲𝗮𝗸𝗲𝗿𝘀:
• Tristan Theurier (General Manager Veeva Systems Asia Pacific): https://www.linkedin.com/in/tristantheurier/
• Guillaume Villard (Host & Founder): https://www.linkedin.com/in/digitalgloballeader/
🔗 𝗟𝗲𝗮𝗿𝗻 𝗺𝗼𝗿𝗲 𝗮𝗯𝗼𝘂𝘁 𝗩𝗲𝗲𝘃𝗮 𝗖𝗼𝗺𝗺𝗲𝗿𝗰𝗶𝗮𝗹 𝗘𝘃𝗶𝗱𝗲𝗻𝗰𝗲: https://www.veeva.com/commercial-evidence/

⏱️ Chapters:
00:00 - Introduction  
01:05 - Patients' landscape is changing 
02:27 - Healthcare Professionals landscape is changing
06:15 - HCPs access & relevance of the SalesRep model in question
09:49 - How Field Reps will evolve
11:03 - Shaping Content for humans & AI (GEO...)
17:18 - How AI helps understand HCPs unmet needs & barriers to adoption?
24:20 - Why Veeva moved away from Salesforce platform?
27:10 - Will AI kill the SaaS business (Software market)?
29:08 - The price of AI, the consumption model & expectations
31:40 - The 3 Key-takeaways of our conversation & closing

#AI #ArtificialIntelligence #Pharma #LifeSciences #MedTech #Healthcare #PharmaCommercial #CommercialExcellence #HCPEngagement #MedicalAffairs #DigitalHealth #GenerativeAI #AIinHealthcare #Veeva #AgenticAI #CommercialEvidence #GEO #GenerativeEngineOptimization

Support the show

Text Amplifiz Podcast

🎧 Amplifiz Pharma & MedTech Innovations Podcast | Featuring Dr. Ankur Gupta (Menarini Group)
In this episode of the Amplifiz Podcast, host Guillaume Villard sits down with Dr. Ankur Gupta to unpack one of the most important transformations in the pharmaceutical industry today: the evolution or reinvention of Medical Affairs.
What used to be a support function focused on compliance and scientific communication is now emerging as a strategic powerhouse—bridging science, business strategy, and patient outcomes.

🚀 What you’ll learn in this episode:
What Medical Affairs really does (in simple terms) and why it’s critical across the entire product lifecycle
How Medical Affairs evolved from a “rubber stamp” function to a core strategic pillar alongside R&D and Commercial
Why COVID-19 accelerated the shift toward patient-centric healthcare models
The growing importance of real-world evidence, data democratization, and precision medicine
Whether pharma is truly patient-centric—or still product-driven
How Medical Affairs can influence care pathways, clinical decision-making, and outcomes
The rise of omnichannel engagement and how to improve HCP (healthcare professional) experience
Leadership lessons for the AI era: balancing digital transformation with emotional intelligence (EI)

🧠 Key frameworks & insights from Dr. Gupta:
Medical Affairs as the “bridge” between evidence generation and real-world implementation.
The AEIOU model for modern Medical Affairs professionals: Empathy, Analysis, Insights, Outcome (patient outcome), Understanding care pathways.
The shift from product-first → patient-first → product + service models.
Why data literacy and digital fluency are now essential skills.
“Digitalize, but don’t dehumanize” — leading in the age of AI.
The importance of being both scientifically rigorous and commercially savvy

🎯 Who should watch:
This episode is designed for professionals across:
Pharma & Biotech, MedTech and Medical Affairs, Commercial & Market Access, Strategy & Innovation functions.

If you’re navigating the future of healthcare, this conversation will give you practical insights, strategic frameworks, and leadership perspectives you can apply immediately.

📌 𝙂𝙪𝙚𝙨𝙩: 𝘼𝙣𝙠𝙪𝙧 𝙂𝙪𝙥𝙩𝙖, 𝙈𝘿, 𝘽𝘾𝙈𝘼𝙎 (𝙂𝙡𝙤𝙗𝙖𝙡 𝙃𝙚𝙖𝙙 𝙛𝙤𝙧 𝙈𝙚𝙙𝙞𝙘𝙖𝙡 𝙎𝙩𝙧𝙖𝙩𝙚𝙜𝙮 & 𝘿𝙚𝙫𝙚𝙡𝙤𝙥𝙢𝙚𝙣𝙩 𝙖𝙩 𝙈𝙚𝙣𝙖𝙧𝙞𝙣𝙞 𝙂𝙧𝙤𝙪𝙥)
📌 𝙃𝙤𝙨𝙩: 𝙂𝙪𝙞𝙡𝙡𝙖𝙪𝙢𝙚 𝙑𝙞𝙡𝙡𝙖𝙧𝙙, 𝙁𝙤𝙪𝙣𝙙𝙚𝙧 & 𝘾𝙀𝙊 𝙤𝙛 𝘼𝙢𝙥𝙡𝙞𝙛𝙞𝙯 𝙋𝙤𝙙𝙘𝙖𝙨𝙩

🔗 Follow Ankur Gupta on LinkedIn: https://www.linkedin.com/in/ankur-guptta-md-bcmas-a147a913/
🔗 Follow Guillaume Villard on LinkedIn: https://www.linkedin.com/in/digitalgloballeader/
🔗 Visit Amplifiz website: https://amplifiz.com
🔗 Follow Amplifiz on LinkedIn: https://www.linkedin.com/company/amplifiz

🕓Timestamps:
0:00 Introduction & context
2:08 How would you define Medical Affairs function? 
3:47 Ankur's global Med-Affairs strategy & development role
5:21 Med-Affairs evolution and where do we go from there?
6:47 Why Covid-19 made Med-Affairs a more strategic function?
08:20 What Med-Affairs Leaders need to master today (EAIOU)?
09:29 How to balance compliance and business mindset for Med-Affairs?
13:07 Data & digital literacy in Med-Affairs
14:28 Use of non-conventional data in Med-Affairs
16:56 How can we really be patient-centric?
21:05 How Med-Affairs can bring value in care pathways?
22:25 Med-Affairs internal dynamic within Pharma
23:42 How HCPs expectations accelerated growth of Med-Affairs?
27:45 reinventing speed, breath & depth of Med-Affairs
30:37 Ankur's leadership style & passion for  emotional intelligence 
32:57 Takeaways for Med-Affairs to reflect on & act-upon
34:35 Wrap-up and conclusion

👥 𝗝𝗼𝗶𝗻 𝗢𝘂𝗿 𝗖𝗼𝗺𝗺𝘂𝗻𝗶𝘁𝘆:
What does true patient centricity look like in your organization?
How is Medical Affairs evolving where you work?
👇 Drop your thoughts, questions, and experiences in the comments!
Don't forget to like, subscribe, and hit the bell icon to stay updated on our latest episodes.

🌐 𝗪𝗲𝗯𝘀𝗶𝘁𝗲: https://amplifiz.com

✨𝗦𝗨𝗕𝗦𝗖𝗥𝗜𝗕𝗘 𝗛𝗘𝗥𝗘
     https://www.youtube.com/@Amplifiz

𝐖𝐚𝐧𝐭 𝐭𝐨 𝐬𝐞𝐞 𝐦𝐨𝐫𝐞 𝐜𝐨𝐧𝐭𝐞𝐧𝐭 𝐥𝐢𝐤𝐞 𝐭𝐡𝐢𝐬...? 
▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬
👍 Like the video (it helps a ton!)
💬 Comment below to share your opinion!
🔗 Share the video with anyone you think might help :)
▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬

📧 𝗙𝗼𝗿 𝗕𝘂𝘀𝗶𝗻𝗲𝘀𝘀 𝗜𝗻𝗾𝘂𝗶𝗿𝗶𝗲𝘀: [email protected]

📱 𝗦𝘁𝗮𝘆 𝗧𝘂𝗻𝗲𝗱 𝗶𝗻 𝗢𝘂𝗿 𝗦𝗼𝗰𝗶𝗮𝗹 𝗠𝗲𝗱𝗶𝗮:
linkedin.com/company/amplifiz
amplifizpodcasts.buzzsprout.com
linkedin.com/in/digitalgloballeader
https://www.instagram.com/amplifiz/
....................................
#Pharma
#medicalaffairs
#patientcentricity
#healthcare innovations
#AmplifizPodcast
#PharmaInnovation 
#HealthcareLeadership 
#PrecisionMedicine

Support the show

Text Amplifiz Podcast

“Strategy” is everywhere in pharma and medtech—but execution is where most organizations fail. or fall short.
In this episode of the Amplifiz Pharma & MedTech Innovations Podcast, host Guillaume Villard sits down with commercial leader Andrés von der Walde to challenge conventional thinking around strategy, organizational change management and commercial innovation in Pharma.
This is not another high-level conversation. It’s a practical, sometimes controversial deep dive into why transformation initiatives fail—and what leaders & professionals must do differently to actually deliver results.

🎯 What You’ll Learn in This Episode
- Why organizational change management is broken (and how to rethink it)
- The dangerous gap between strategy and real-world execution
- Why most Pilots end up in a “museum of innovation” instead of scaling & delivering tangible impact at scale
- How to balance innovation vs. day-to-day business pressure
- The concept of “obsession with what can go wrong”—and why it’s critical
- Why AI, omnichannel, and data strategies fail at scale in Pharma
- The truth about Next Best Action (NBA) and why it can backfire
- How leaders can build real ownership (not black-box innovation)

💡 Key Takeaway
There is no such thing as a “plug-and-play” transformation.

If you want innovation to work in Pharma or MedTech, you must:
- Engineer it for real-world complexity
- Align it with daily operations
- And most importantly, own the process—not outsource it

🧠 Who Should Watch This?
This episode is a must-watch for:
- Pharma & MedTech executives
- Commercial, Medical Affairs, and Omnichannel leaders
- Digital & AI transformation teams
- Anyone working on customer engagement, data strategy, or innovation at scale
- Consultants & Tech providers

📌 𝙂𝙪𝙚𝙨𝙩: 𝘼𝙣𝙙𝙧é𝙨 𝙫𝙤𝙣 𝙙𝙚𝙧 𝙒𝙖𝙡𝙙𝙚 (𝙎𝙚𝙣𝙞𝙤𝙧 𝘿𝙞𝙧𝙚𝙘𝙩𝙤𝙧 - 𝘾𝙪𝙨𝙩𝙤𝙢𝙚𝙧 𝙀𝙣𝙜𝙖𝙜𝙚𝙢𝙚𝙣𝙩 & 𝘾𝙖𝙥𝙖𝙗𝙞𝙡𝙞𝙩𝙞𝙚𝙨 - 𝙍𝙚𝙜𝙞𝙤𝙣 𝘼𝙨𝙞𝙖 𝙋𝙖𝙘𝙞𝙛𝙞𝙘 𝙖𝙩 𝙉𝙤𝙫𝙤 𝙉𝙤𝙧𝙙𝙞𝙨𝙠)
📌 𝙃𝙤𝙨𝙩: 𝙂𝙪𝙞𝙡𝙡𝙖𝙪𝙢𝙚 𝙑𝙞𝙡𝙡𝙖𝙧𝙙, 𝙁𝙤𝙪𝙣𝙙𝙚𝙧 & 𝘾𝙀𝙊 𝙤𝙛 𝘼𝙢𝙥𝙡𝙞𝙛𝙞𝙯 𝙋𝙤𝙙𝙘𝙖𝙨𝙩

🔗 Follow Andrés von der Walde on LinkedIn: https://www.linkedin.com/in/vonderwalde/
🔗 Follow Guillaume Villard on LinkedIn: https://www.linkedin.com/in/digitalgloballeader/
🔗 Visit Amplifiz website: https://amplifiz.com
🔗 Follow Amplifiz on LinkedIn: https://www.linkedin.com/company/amplifiz

🕓Timestamps:
0:00 Intro, objectives & disclaimer
1:23 What is wrong with Change Management? 
5:13 Being obsessed with what can go wrong
9:31 Why do people get cynical and how to create synergies?
15:22 Working with proximate objectives to engineer change
18:53: Why Tech sovereignty is key for Leaders?
25:53: State of Commercial Pharma innovation today
28:34 What gets you excited in Pharma and your take on Next Best Action 
33:20 Wrap-up and conclusion

-------------------
Pharma strategy execution, medtech transformation, pharmaceutical commercial excellence, omnichannel pharma, AI in pharma, next best action pharma, change management healthcare, pharma digital transformation, HCP engagement strategy, data-driven pharma, innovation in healthcare, commercial pharma leadership
-------------------

👥 𝗝𝗼𝗶𝗻 𝗢𝘂𝗿 𝗖𝗼𝗺𝗺𝘂𝗻𝗶𝘁𝘆:
Share your experiences and thoughts about this episode in the comments below!
Don't forget to like, subscribe, and hit the bell icon to stay updated on our latest episodes.

🌐 𝗪𝗲𝗯𝘀𝗶𝘁𝗲: https://amplifiz.com

✨𝗦𝗨𝗕𝗦𝗖𝗥𝗜𝗕𝗘 𝗛𝗘𝗥𝗘
     https://www.youtube.com/@Amplifiz

𝐖𝐚𝐧𝐭 𝐭𝐨 𝐬𝐞𝐞 𝐦𝐨𝐫𝐞 𝐜𝐨𝐧𝐭𝐞𝐧𝐭 𝐥𝐢𝐤𝐞 𝐭𝐡𝐢𝐬...? 
▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬
👍 Like the video (it helps a ton!)
💬 Comment below to share your opinion!
🔗 Share the video with anyone you think might help :)
▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬

📧 𝗙𝗼𝗿 𝗕𝘂𝘀𝗶𝗻𝗲𝘀𝘀 𝗜𝗻𝗾𝘂𝗶𝗿𝗶𝗲𝘀: [email protected]

📱 𝗦𝘁𝗮𝘆 𝗧𝘂𝗻𝗲𝗱 𝗶𝗻 𝗢𝘂𝗿 𝗦𝗼𝗰𝗶𝗮𝗹 𝗠𝗲𝗱𝗶𝗮:
linkedin.com/company/amplifiz
amplifizpodcasts.buzzsprout.

Support the show

Text Amplifiz Podcast

Are you a successful Pharma or MedTech leader… but still feeling constantly tired, low on energy, or burned out?
In this powerful episode of the Amplifiz Podcast, we sit down with Shirley Low from Johnson & Johnson to uncover a hard truth: career success means nothing without health.
After years in MedTech, Shirley shares her personal wake-up call—from chronic fatigue and health struggles to rebuilding her energy in just 3 months. Her journey will challenge how you think about performance, leadership, and well-being.

Shirley Loh is not only a successful Professional Education Leader and a Credo Champion at Johnson & Johnson Vision Care (her LinkedIn here:   / shirleyloh  , she is also one of the most driven and generous person we probably ever had on the show! Discover Shirley's amazing story and how she fixed her health and energy in 3 Months and what other MedTech & Pharma professionals can learn from her!

Career achievements should never be at the expense of your well-being and your health. Shirley  provides practical guidance and tips all professionals can apply to themselves, don't wait for your health to derail to do what is right for you and what will help you drive your career & your life to new height.

In this episode, you’ll discover:
💡 Why high-performing leaders often feel exhausted
💡 The hidden cost of ignoring your health as a busy professional
💡 The difference between “normal” and optimal health
💡 How to regain your energy, focus, and performance
💡 Practical ways to take control of your physical & mental well-being

If you’re serious about long-term success, this conversation might change how you prioritize your life.

⏱️ Timestamps
00:00 – Introduction
00:56 – What success really means in MedTech?
01:58 – Shirley’s health wake-up call
04:14 – Discovering the root cause (thyroid, iron, fatigue)
05:20 – From fatigue/burnout to high performance
06:09 – Picking-up Marathon at 42 years old and learning about our health
07:23 – Any flip side on tracking our health? 
09:57 – How to get support?
11:00 – How Shirley' story resonates with Guillaume's weight loss journey and how to maintain good habits long term
13:59 – Shirley's roles at J&J Vision Care and her true passion in helping others

Support the show

Text Amplifiz Podcast

Cesar G Concepcion, Chief Commercial Officer (APMA Region) at Novartis is a proven Pharma Executive with 39 years of international commercial experience across the US, Europe, China, South-East Asia & Middle-East Africa...
Cesar is the guest of this Amplifiz Pharma and MedTech Innovations Podcast episode hosted by Guillaume Villard on which he talks about his passion and deep experience in Product Launch. Throughout his journey, he has launched countless number of new Medical Brands, and has gathered clarity on what can make or break your Commercial success and the future of your Pharma.BioPharma Organization.

On this insightful Podcast episode, Cesar candidly shares amazing stories and lessons learned that he gathered throughout his Leadership journey. He talks about his scope with Novartis APMA Region (Asia-Pacific Middle-East Africa) covering 33 Markets directly and running a business of ~ 5 billion $. What it means to launch new products in diverse markets like APMA, what are the elements and pre-requisites required to evaluate if an Organization is ready to launch a new asset, how to collaborate cross-functionally, the critical role of a Brand Lead, what to do and what not to do when it comes to launching a new medicine. The interactions and input needed from Healthcare Professionals, Patients but also Payers. Leadership lessons learned and advice to future generation, role of AI - Artificial Intelligence in the current and future Commercial engine of Pharma and much more.
 

📌 𝗚𝘂𝗲𝘀𝘁: 𝗖𝗲𝘀𝗮𝗿 𝗖𝗼𝗻𝗰𝗲𝗽𝗰𝗶𝗼𝗻, 𝗖𝗵𝗶𝗲𝗳 𝗖𝗼𝗺𝗺𝗲𝗿𝗰𝗶𝗮𝗹 𝗢𝗳𝗳𝗶𝗰𝗲𝗿 𝗮𝘁 𝗡𝗼𝘃𝗮𝗿𝘁𝗶𝘀
📌 𝗛𝗼𝘀𝘁: 𝗚𝘂𝗶𝗹𝗹𝗮𝘂𝗺𝗲 𝗩𝗶𝗹𝗹𝗮𝗿𝗱, 𝗙𝗼𝘂𝗻𝗱𝗲𝗿 & 𝗖𝗘𝗢 𝗼𝗳 𝗔𝗺𝗽𝗹𝗶𝗳𝗶𝘇 𝗣𝗼𝗱𝗰𝗮𝘀𝘁

🔗 Follow Cesar G Concepcion on LinkedIn: https://www.linkedin.com/in/cesar-g-concepcion-565245/
🔗 Follow Guillaume Villard on LinkedIn: https://www.linkedin.com/in/digitalgloballeader/
🔗 Visit Amplifiz website: https://amplifiz.com
🔗 Follow Amplifiz on LinkedIn: https://www.linkedin.com/company/amplifiz

🕓Timestamps:
0:00 Intro  
0:50 How to define successful launch?
2:00 How to launch in very diverse markets?
3:45 Define "what not to do"
5:45 Define "must-wins" & role of Brand Lead
7:25: Internal teams supporting a Launch
10:18 HCPs & Patients' engagement for Launch
13:13 Not rushing a Launch if not ready - Discussing with C-level
15:28 Adjusting Go To Market when losing patent 
17:15 Smaller markets more creative in innovating
18:58 Traits of a successful Brand owner
20:40 Is Pharma engaging HCPs properly? Let's talk customer centricity
26:29: More about your role at Novartis and the business in APMA
28:02 How to build consensus in Enterprises?
30:10 Reflecting on lessons you learn as a Leader
34:16 Your take on AI in Pharma and what is to come
37:18 Wrap-up and conclusion

👥 𝗝𝗼𝗶𝗻 𝗢𝘂𝗿 𝗖𝗼𝗺𝗺𝘂𝗻𝗶𝘁𝘆:
Share your experiences and thoughts about this episode in the comments below!
Don't forget to like, subscribe, and hit the bell icon to stay updated on our latest episodes.

🌐 𝗪𝗲𝗯𝘀𝗶𝘁𝗲: https://amplifiz.com

✨𝗦𝗨𝗕𝗦𝗖𝗥𝗜𝗕𝗘 𝗛𝗘𝗥𝗘
     https://www.youtube.com/@Amplifiz

𝐖𝐚𝐧𝐭 𝐭𝐨 𝐬𝐞𝐞 𝐦𝐨𝐫𝐞 𝐜𝐨𝐧𝐭𝐞𝐧𝐭 𝐥𝐢𝐤𝐞 𝐭𝐡𝐢𝐬...? 
▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬
👍 Like the video (it helps a ton!)
💬 Comment below to share your opinion!
🔗 Share the video with anyone you think might help :)
▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬

📧 𝗙𝗼𝗿 𝗕𝘂𝘀𝗶𝗻𝗲𝘀𝘀 𝗜𝗻𝗾𝘂𝗶𝗿𝗶𝗲𝘀: [email protected]

📱 𝗦𝘁𝗮𝘆 𝗧𝘂𝗻𝗲𝗱 𝗶𝗻 𝗢𝘂𝗿 𝗦𝗼𝗰𝗶𝗮𝗹 𝗠𝗲𝗱𝗶𝗮:
linkedin.com/company/amplifiz
amplifizpodcasts.buzzsprout.com
linkedin.com/in/digitalgloballeader
https://www.instagram.com/amplifiz/
....................................
#Pharma
#LaunchExcellence
#Novartis
#Commercial
#Executive
#AmplifizPodcast

Support the show

Text Amplifiz Podcast

Peter Sallstig, Global Head Product Development Division and Chief Medical Officer at Santen Pharma (https://www.santen.com/) is the guest of this Amplifiz Pharma and MedTech Innovations Podcast episode hosted by Guillaume Villard.

Peter Sallstig has an impressive international Leadership experience in Pharma working and living across Asia, USA, Europe.
On this insightful Podcast episode, Peter candidly shares amazing stories and lessons learned that he gathered throughout his Leadership journey. He talks about Santen Pharma, a global leader in eye-care/Ophthalmology. In  this episode, we also dive into his  two roles as both Head of Product Development and Chief Medical Officer,  the history, vision and pipeline of Santen Pharma and much more insights about leading multi-cultural Organizations.
 

📌 𝗚𝘂𝗲𝘀𝘁: 𝗣𝗲𝘁𝗲𝗿 𝗦𝗮𝗹𝗹𝘀𝘁𝗶𝗴, 𝗚𝗹𝗼𝗯𝗮𝗹 𝗛𝗲𝗮𝗱 𝗣𝗿𝗼𝗱𝘂𝗰𝘁 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 𝗗𝗶𝘃𝗶𝘀𝗶𝗼𝗻 𝗮𝗻𝗱 𝗖𝗵𝗶𝗲𝗳 𝗠𝗲𝗱𝗶𝗰𝗮𝗹 𝗢𝗳𝗳𝗶𝗰𝗲𝗿 𝗮𝘁 𝗦𝗮𝗻𝘁𝗲𝗻 𝗣𝗵𝗮𝗿𝗺𝗮 
📌 𝗛𝗼𝘀𝘁: 𝗚𝘂𝗶𝗹𝗹𝗮𝘂𝗺𝗲 𝗩𝗶𝗹𝗹𝗮𝗿𝗱, 𝗙𝗼𝘂𝗻𝗱𝗲𝗿 & 𝗖𝗘𝗢 𝗼𝗳 𝗔𝗺𝗽𝗹𝗶𝗳𝗶𝘇 𝗣𝗼𝗱𝗰𝗮𝘀𝘁

🔗 Follow Peter Sallstig on LinkedIn: https://www.linkedin.com/in/peter-sallstig/
🔗 Follow Guillaume Villard on LinkedIn: https://www.linkedin.com/in/digitalgloballeader/
🔗 Follow Amplifiz on LinkedIn: https://www.linkedin.com/company/amplifiz

🕓Timestamps:
0:00 Intro & more about your roles at Santen
2:58 Tell us more about Santen
5:40 Your background & international experience
7:19 How to design consensus in global Organizations?
9:06 Global governance vs local empowerment?
11:57: Traits you look for when hiring at Santen?
15:38 Defining success
18:38 Your Leadership DNA
13:35 what are the main vulnerabilities of MedTech in terms of cybersecurity?
20:32 Pitfalls you tend to alert future leaders about?
22:40 Advise to your younger self
25:28 Santen recent treatment approval in Japan and Europe 
26:28 Santen mid-term/long-term pipeline
28:52: Market Access & Competition in China
31:12 AI in Pharma, your belief & aspirations
36:22 Wrap-up and conclusion

👥 𝗝𝗼𝗶𝗻 𝗢𝘂𝗿 𝗖𝗼𝗺𝗺𝘂𝗻𝗶𝘁𝘆:
Share your experiences and thoughts about this episode in the comments below!
Don't forget to like, subscribe, and hit the bell icon to stay updated on our latest episodes.

🌐 𝗪𝗲𝗯𝘀𝗶𝘁𝗲: https://www.linkedin.com/company/amplifiz/
 
✨𝗦𝗨𝗕𝗦𝗖𝗥𝗜𝗕𝗘 𝗛𝗘𝗥𝗘
     https://www.youtube.com/@Amplifiz

𝐖𝐚𝐧𝐭 𝐭𝐨 𝐬𝐞𝐞 𝐦𝐨𝐫𝐞 𝐜𝐨𝐧𝐭𝐞𝐧𝐭 𝐥𝐢𝐤𝐞 𝐭𝐡𝐢𝐬...? 
▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬
👍 Like the video (it helps a ton!)
💬 Comment below to share your opinion!
🔗 Share the video with anyone you think might help :)
▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬

📧 𝗙𝗼𝗿 𝗕𝘂𝘀𝗶𝗻𝗲𝘀𝘀 𝗜𝗻𝗾𝘂𝗶𝗿𝗶𝗲𝘀: [email protected]

📱 𝗦𝘁𝗮𝘆 𝗧𝘂𝗻𝗲𝗱 𝗶𝗻 𝗢𝘂𝗿 𝗦𝗼𝗰𝗶𝗮𝗹 𝗠𝗲𝗱𝗶𝗮:
linkedin.com/company/amplifiz
amplifizpodcasts.buzzsprout.com
linkedin.com/in/digitalgloballeader
....................................
#Pharma
#Ophthalmology
#Santen 
#MedicalAffairs
#Eyecare
#AmplifizPodcast

Support the show

Text Amplifiz Podcast

MedTech, Health-Tech and Medical Devices are very often connected devices and yet cybersecurity considerations are too often overlooked by Entrepreneurs, Innovators, Product Teams whether in startups/scaleups or large MNCs!

Learn from a cybersecurity veteran and MedTech expert, Christian Espinosa (https://www.linkedin.com/in/christianespinosa/), the founder of Blue Goat Cyber (https://bluegoatcyber.com/) on why and how to turn cybersecurity into a critical enabler to your product and business' success and not a road block to your regulatory approval.

Christian breaks it all down for us and turns a complex topic into easily understandable and practical guidance for all MedTech professionals to consider.    
This episode provides clear guidance on how to seamlessly integrate cybersecurity as a core component of your Product, why it matters, what are the pitfalls to avoid and best practices to apply not just to meet FDA, MDR or other regulatory requirements but to meet Customers' requirements and ensure patient' safety.

📌 𝗚𝘂𝗲𝘀𝘁: 𝗖𝗵𝗿𝗶𝘀𝘁𝗶𝗮𝗻 𝗘𝘀𝗽𝗶𝗻𝗼𝘀𝗮, 𝗙𝗼𝘂𝗻𝗱𝗲𝗿 & 𝗖𝗘𝗢 of 𝗕𝗹𝘂𝗲 𝗚𝗼𝗮𝘁 𝗖𝘆𝗯𝗲𝗿
📌 𝗛𝗼𝘀𝘁: 𝗚𝘂𝗶𝗹𝗹𝗮𝘂𝗺𝗲 𝗩𝗶𝗹𝗹𝗮𝗿𝗱, 𝗙𝗼𝘂𝗻𝗱𝗲𝗿 & 𝗖𝗘𝗢 𝗼𝗳 𝗔𝗺𝗽𝗹𝗶𝗳𝗶𝘇 𝗣𝗼𝗱𝗰𝗮𝘀𝘁

🔗 Follow Christian Espinosa on LinkedIn: https://www.linkedin.com/in/christianespinosa/
🔗 Follow Blue Goat Cyber on LinkedIn: https://www.linkedin.com/company/blue-goat-cyber/
🔗 Learn more about Blue Goat Cyber: https://bluegoatcyber.com
🔗 Follow Blue Goat Cyber Podcast: https://youtube.com/playlist?list=PLWQj_E9ypCcTB1m-s4920VYxm1xNHraBW&si=aYRIVTZfHEWynOU6
🔗 Follow Guillaume Villard: https://www.linkedin.com/in/digitalgloballeader/


🕓Timestamps:
0:00 Intro
0:48 Christian Espinosa's background and personal story leading him to MedTech
3:47 Impact when cybersecurity is over-looked in MedTech?
6:52 What are the cybersecurity requirements from Regulators? 
9:06 Who are your Customers?
10:33: What is the gap between cyber risk, compliance & innovation? 
12:45 Who are the main stakeholders you support and work with? 
13:35 what are the main vulnerabilities of MedTech in terms of cybersecurity?
15:33 How MedTech and Healthcare Providers work on cybersecurity together?
18:40 Are Hospitals equipped with the right expertise and resources to ensure cybersecurity?
22:16 How does AI change the landscape in MedTech cybersecurity?
26:53 What are the main misconceptions around cybersecurity in MedTech?
30:05 How do you educate the Industry about cyber security?
31:45 What advice would you give to your younger-self?
33:13 Wrap-up and conclusion


👥 𝗝𝗼𝗶𝗻 𝗢𝘂𝗿 𝗖𝗼𝗺𝗺𝘂𝗻𝗶𝘁𝘆:
Share your experiences and thoughts about this episode in the comments below!
Don't forget to like, subscribe, and hit the bell icon to stay updated on our latest episodes.

🌐 𝗪𝗲𝗯𝘀𝗶𝘁𝗲: https://www.linkedin.com/company/amplifiz/
 
✨𝗦𝗨𝗕𝗦𝗖𝗥𝗜𝗕𝗘 𝗛𝗘𝗥𝗘
     https://www.youtube.com/@Amplifiz

𝐖𝐚𝐧𝐭 𝐭𝐨 𝐬𝐞𝐞 𝐦𝐨𝐫𝐞 𝐜𝐨𝐧𝐭𝐞𝐧𝐭 𝐥𝐢𝐤𝐞 𝐭𝐡𝐢𝐬...? 
▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬
👍 Like the video (it helps a ton!)
💬 Comment below to share your opinion!
🔗 Share the video with anyone you think might help :)
▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬

📧 𝗙𝗼𝗿 𝗕𝘂𝘀𝗶𝗻𝗲𝘀𝘀 𝗜𝗻𝗾𝘂𝗶𝗿𝗶𝗲𝘀: [email protected]

📱 𝗦𝘁𝗮𝘆 𝗧𝘂𝗻𝗲𝗱 𝗶𝗻 𝗢𝘂𝗿 𝗦𝗼𝗰𝗶𝗮𝗹 𝗠𝗲𝗱𝗶𝗮:
linkedin.com/company/amplifiz
amplifizpodcasts.buzzsprout.com
linkedin.com/in/digitalgloballeader
....................................
#MedTech
#Cybersecurity
#RegulatoryAffairs
#LifeSciences
#DigitalHealth
#Health-Tech
#HealthcareInnovation
#AmplifizPodcast

Support the show

Text Amplifiz Podcast

Wondering what is the current and future state of Regulatory Affairs and Compliance in Pharma and MedTech? On this insightful Amplifiz Podcast episode, our host Guillaume Villard (https://www.linkedin.com/in/digitalgloballeader/) welcomes Caroline Shleifer ((https://www.linkedin.com/in/caroline-shleifer/), Founder & CEO of RegASK, a leading AI-driven regulatory intelligence platform built for Pharma, MedTech, and other highly regulated industries.

Caroline shares great insights from RegASK’s latest 2026 State of Regulatory Affairs & Compliance Report (https://regask.com/the-2026-state-of-regulatory-affairs-and-compliance-report/) and provides analysis of the evolving role, challenges & opportunities of Regulatory Affairs and Compliance functions in Pharma and MedTech. She discusses how these functions can better bridge the gap between innovation and market access in an increasingly complex and AI-powered global ecosystem.

This episode provides clear guidance to both Regulatory Affairs & Compliance teams on how to operate more seamlessly, reduce manual work & leverage AI to better scan and navigate complex regulations locally, regionally, globally.

For non-Regulatory Affairs experts, this podcast episode provides a better understanding of the critical role of Regulatory Affairs in Pharma and MedTech and the value they enable to the broader commercial organization.

👥 𝗝𝗼𝗶𝗻 𝗢𝘂𝗿 𝗖𝗼𝗺𝗺𝘂𝗻𝗶𝘁𝘆:
Share your experiences and thoughts about this episode in the comments below!
Don't forget to like, subscribe, and hit the bell icon to stay updated on our latest episodes.

🌐 𝗪𝗲𝗯𝘀𝗶𝘁𝗲: https://www.linkedin.com/company/amplifiz/
 
✨𝗦𝗨𝗕𝗦𝗖𝗥𝗜𝗕𝗘 𝗛𝗘𝗥𝗘
     https://www.youtube.com/@Amplifiz

𝐖𝐚𝐧𝐭 𝐭𝐨 𝐬𝐞𝐞 𝐦𝐨𝐫𝐞 𝐜𝐨𝐧𝐭𝐞𝐧𝐭 𝐥𝐢𝐤𝐞 𝐭𝐡𝐢𝐬...? 
▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬
👍 Like the video (it helps a ton!)
💬 Comment below to share your opinion!
🔗 Share the video with anyone you think might help :)
▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬

📧 𝗙𝗼𝗿 𝗕𝘂𝘀𝗶𝗻𝗲𝘀𝘀 𝗜𝗻𝗾𝘂𝗶𝗿𝗶𝗲𝘀: [email protected]

📱 𝗦𝘁𝗮𝘆 𝗧𝘂𝗻𝗲𝗱 𝗶𝗻 𝗢𝘂𝗿 𝗦𝗼𝗰𝗶𝗮𝗹 𝗠𝗲𝗱𝗶𝗮:
linkedin.com/company/amplifiz
amplifizpodcasts.buzzsprout.com
linkedin.com/in/digitalgloballeader
....................................
#AIInLifeSciences
#GenAI
#RegulatoryAffairs
#Compliance
#PharmaInnovation
#MedTech
#LifeSciencesAI
#DigitalHealth
#FutureOfHealthcare
#PharmaTech
#HealthcareInnovation
#BiotechAI
#HealthcareTrends
#AmplifizPodcast
#PharmaDigitalTransformation
#AIRevolution

Support the show

Text Amplifiz Podcast

MedTech World CEO (Dylan Attard: https://www.linkedin.com/in/dylattard/) reflects on his Entrepreneurial journey, where MedTech World is heading to and what MedTech innovators should consider doing and avoid doing to raise money and succeed! Dylan Attard, co-Founder & CEO of MedTech World is our latest guest on Amplifiz Podcast. He is a surgeon by training and now helping MedTech Founders, startups, scaleups to meet Investors, Accelerators, Large MNCs via his successful Event organization: MedTech World! https://med-tech.world

Dylan is pursuing a meaningful mission of helping innovations to scale and reach as many patients as possible all around the World.

On this Podcast he talks about:
- MedTech World mission and ambition
- His personal journey as an Entrepreneur 
- Shaping his own goals and define success
- His advice to Founders in MedTech, Health-Tech to raise money and grow their businesses
- His perception on the current market outlook for investments in MedTech in the US, Europe, Middle East/Africa and Asia Pacific.

👥 𝗝𝗼𝗶𝗻 𝗢𝘂𝗿 𝗖𝗼𝗺𝗺𝘂𝗻𝗶𝘁𝘆:
Share your experiences and thoughts about this episode in the comments below!
Don't forget to like, subscribe, and hit the bell icon to stay updated on our latest episodes.

🌐 𝗪𝗲𝗯𝘀𝗶𝘁𝗲: https://www.linkedin.com/company/amplifiz/
 
✨𝗦𝗨𝗕𝗦𝗖𝗥𝗜𝗕𝗘 𝗛𝗘𝗥𝗘
     https://www.youtube.com/@Amplifiz

𝐖𝐚𝐧𝐭 𝐭𝐨 𝐬𝐞𝐞 𝐦𝐨𝐫𝐞 𝐜𝐨𝐧𝐭𝐞𝐧𝐭 𝐥𝐢𝐤𝐞 𝐭𝐡𝐢𝐬...? 
▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬
👍 Like the video (it helps a ton!)
💬 Comment below to share your opinion!
🔗 Share the video with anyone you think might help :)
▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬

📧 𝗙𝗼𝗿 𝗕𝘂𝘀𝗶𝗻𝗲𝘀𝘀 𝗜𝗻𝗾𝘂𝗶𝗿𝗶𝗲𝘀: [email protected]

📱 𝗦𝘁𝗮𝘆 𝗧𝘂𝗻𝗲𝗱 𝗶𝗻 𝗢𝘂𝗿 𝗦𝗼𝗰𝗶𝗮𝗹 𝗠𝗲𝗱𝗶𝗮:
linkedin.com/company/amplifiz
amplifizpodcasts.buzzsprout.com
linkedin.com/in/digitalgloballeader
....................................
#MedTechWorld
#DylanAttard
#amplifizpodcast 
#MedTechInnovation
#HealthTech
#MedicalTechnology
#HealthcareInnovation
#MedTechStartups
#Entrepreneurship
#StartupGrowth
#InvestorRelations
#digitalhealthces 
#HealthcareInvesting
#MedTechFounders
#HealthTechLeaders
#GlobalHealthcare
#MedicalEntrepreneur
#InnovationInHealthcare
#MedTechConference
#AmplifyInnovation

Support the show

Text Amplifiz Podcast

On this insightful Amplifiz Podcast episode, our host Guillaume Villard (https://www.linkedin.com/in/digitalgloballeader/) welcomes Felyn Tan, Client Partner Life Sciences at Cognizant to discuss the key trends and use cases Pharma and MedTech explore today and should look to explore tomorrow, What business problems to tackle first and how to better understand and leverage Gen AI and Agentic AI in Pharma, MedTech and Life Sciences workflows in 2025/2026. 
Follow Felyn Tan on LinkedIn here: https://www.linkedin.com/in/felyn-tan/ or have more information about Cognizant's expertise with this ebook about how Agentic AI is reshaping life sciences by accelerating commercialization, while also driving efficiency and innovation across R&D and manufacturing: www.cognizant.com/sg/en/cmp/agentic-ai-in-life-sciences

Cognizant’s approach is grounded in deep life sciences process and systems expertise, built through years of partnering with leading pharmaceutical and biotech companies embedding advanced AI across the entire value chain - from R&D to manufacturing, commercial operations, and compliance. They  help clients accelerate innovation, reduce operational friction, and make smarter decisions at scale.
👥 𝗝𝗼𝗶𝗻 𝗢𝘂𝗿 𝗖𝗼𝗺𝗺𝘂𝗻𝗶𝘁𝘆:
Share your experiences and thoughts about this episode in the comments below!
Don't forget to like, subscribe, and hit the bell icon to stay updated on our latest episodes.

📩 𝗣𝗮𝗿𝘁𝗻𝗲𝗿 𝗪𝗶𝘁𝗵 𝗨𝘀
To be featured on Amplifiz Podcast as a Partner Brand or to run Ads, contact us at: [email protected]

🌐 𝗪𝗲𝗯𝘀𝗶𝘁𝗲: https://www.linkedin.com/company/amplifiz/
 
✨𝗦𝗨𝗕𝗦𝗖𝗥𝗜𝗕𝗘 𝗛𝗘𝗥𝗘
     https://www.youtube.com/@Amplifiz

𝐖𝐚𝐧𝐭 𝐭𝐨 𝐬𝐞𝐞 𝐦𝐨𝐫𝐞 𝐜𝐨𝐧𝐭𝐞𝐧𝐭 𝐥𝐢𝐤𝐞 𝐭𝐡𝐢𝐬...? 
▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬
👍 Like the video (it helps a ton!)
💬 Comment below to share your opinion!
🔗 Share the video with anyone you think might help :)
▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬
 
📧 𝗙𝗼𝗿 𝗕𝘂𝘀𝗶𝗻𝗲𝘀𝘀 𝗜𝗻𝗾𝘂𝗶𝗿𝗶𝗲𝘀: [email protected]

📱 𝗦𝘁𝗮𝘆 𝗧𝘂𝗻𝗲𝗱 𝗶𝗻 𝗢𝘂𝗿 𝗦𝗼𝗰𝗶𝗮𝗹 𝗠𝗲𝗱𝗶𝗮:
linkedin.com/company/amplifiz
amplifizpodcasts.buzzsprout.com
linkedin.com/in/digitalgloballeader
....................................
#AIInLifeSciences
#GenAI
#AgenticAI
#PharmaInnovation
#MedTech
#LifeSciencesAI
#DigitalHealth
#FutureOfHealthcare
#PharmaTech
#HealthcareInnovation
#BiotechAI
#AIForGood
#DrugDiscoveryAI
#HealthcareTrends
#AmplifizPodcast
#PharmaDigitalTransformation
#HealthcareFuture
#MedTechInnovation
#LifeSciencesInnovation
#AIRevolution

Support the show